264 related articles for article (PubMed ID: 33440670)
1. Pharmacogenetics of Direct Oral Anticoagulants: A Systematic Review.
Raymond J; Imbert L; Cousin T; Duflot T; Varin R; Wils J; Lamoureux F
J Pers Med; 2021 Jan; 11(1):. PubMed ID: 33440670
[TBL] [Abstract][Full Text] [Related]
2. The Distribution of the Genotypes of
Abdrakhmanov A; Akilzhanova A; Shaimerdinova A; Zhalbinova M; Tuyakova G; Abildinova S; Albayev R; Ainabekova B; Chinybayeva A; Suleimen Z; Bekbossynova M
Genes (Basel); 2023 May; 14(6):. PubMed ID: 37372371
[TBL] [Abstract][Full Text] [Related]
3. The impact of
Sychev DA; Levanov AN; Shelekhova TV; Bochkov PO; Denisenko NP; Ryzhikova KA; Mirzaev KB; Grishina EA; Gavrilov MA; Ramenskaya GV; Kozlov AV; Bogoslovsky T
Pharmgenomics Pers Med; 2018; 11():127-137. PubMed ID: 30100750
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenomics of Novel Direct Oral Anticoagulants: Newly Identified Genes and Genetic Variants.
Kanuri SH; Kreutz RP
J Pers Med; 2019 Jan; 9(1):. PubMed ID: 30658513
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics of Bleeding and Thromboembolic Events in Direct Oral Anticoagulant Users.
Lähteenmäki J; Vuorinen AL; Pajula J; Harno K; Lehto M; Niemi M; van Gils M
Clin Pharmacol Ther; 2021 Sep; 110(3):768-776. PubMed ID: 34043814
[TBL] [Abstract][Full Text] [Related]
6. The Impact of ABCB1 and CES1 Polymorphisms on Dabigatran Pharmacokinetics in Healthy Chinese Subjects.
Liu Y; Yang C; Qi W; Pei Z; Xue W; Zhu H; Dong M; Guo Y; Cong D; Wang F
Pharmgenomics Pers Med; 2021; 14():477-485. PubMed ID: 33935512
[TBL] [Abstract][Full Text] [Related]
7. The impact of ABCB1 and CES1 polymorphisms on dabigatran pharmacokinetics and pharmacodynamics in patients with atrial fibrillation.
Ji Q; Zhang C; Xu Q; Wang Z; Li X; Lv Q
Br J Clin Pharmacol; 2021 May; 87(5):2247-2255. PubMed ID: 33179295
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics of dabigatran etexilate interindividual variability.
Dimatteo C; D'Andrea G; Vecchione G; Paoletti O; Cappucci F; Tiscia GL; Buono M; Grandone E; Testa S; Margaglione M
Thromb Res; 2016 Aug; 144():1-5. PubMed ID: 27261537
[TBL] [Abstract][Full Text] [Related]
9. Dabigatran etexilate activation is affected by the CES1 genetic polymorphism G143E (rs71647871) and gender.
Shi J; Wang X; Nguyen JH; Bleske BE; Liang Y; Liu L; Zhu HJ
Biochem Pharmacol; 2016 Nov; 119():76-84. PubMed ID: 27614009
[TBL] [Abstract][Full Text] [Related]
10. A simple and fast HPLC-MS/MS method for simultaneous determination of direct oral anticoagulants apixaban, dabigatran, rivaroxaban in human plasma.
Lagoutte-Renosi J; Le Poupon J; Girard A; Montange D; Davani S
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Nov; 1100-1101():43-49. PubMed ID: 30292948
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacogenomic Research in Direct Oral Anticoagulants].
Liu XM; DU LP; Liu B
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Aug; 42(4):562-565. PubMed ID: 32895112
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics in cardiovascular diseases: State of the art and implementation-recommendations of the French National Network of Pharmacogenetics (RNPGx).
Lamoureux F; Duflot T;
Therapie; 2017 Apr; 72(2):257-267. PubMed ID: 28237404
[TBL] [Abstract][Full Text] [Related]
13. Using Pharmacogenetics of Direct Oral Anticoagulants to Predict Changes in Their Pharmacokinetics and the Risk of Adverse Drug Reactions.
Shnayder NA; Petrova MM; Shesternya PA; Savinova AV; Bochanova EN; Zimnitskaya OV; Pozhilenkova EA; Nasyrova RF
Biomedicines; 2021 Apr; 9(5):. PubMed ID: 33922084
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetic studies with oral anticoagulants. Genome-wide association studies in vitamin K antagonist and direct oral anticoagulants.
Cullell N; Carrera C; Muiño E; Torres N; Krupinski J; Fernandez-Cadenas I
Oncotarget; 2018 Jun; 9(49):29238-29258. PubMed ID: 30018749
[TBL] [Abstract][Full Text] [Related]
15. The impact of
Skripka AI; Krupenin PM; Kozhanova ON; Kudryavtseva AA; Fedina LV; Akmalova KA; Bochkov PO; Sokolova AA; Napalkov DA; Sychev DA
Drug Metab Pers Ther; 2024 Jul; ():. PubMed ID: 38943286
[TBL] [Abstract][Full Text] [Related]
16. Role of
Cumitini L; Renda G; Giordano M; Rolla R; Shail T; Sacchetti S; Iezzi L; Giacomini L; Zanotti V; Auciello R; Angilletta I; Foglietta M; Zucchelli M; Antonucci I; Stuppia L; Gallina S; Dianzani U; Patti G
J Clin Med; 2024 Apr; 13(9):. PubMed ID: 38731074
[No Abstract] [Full Text] [Related]
17. Clinical Pharmacokinetics and Pharmacodynamics of Direct Oral Anticoagulants in Patients with Renal Failure.
Padrini R
Eur J Drug Metab Pharmacokinet; 2019 Feb; 44(1):1-12. PubMed ID: 30167998
[TBL] [Abstract][Full Text] [Related]
18. Association of ABCB1 gene polymorphisms rs1128503, rs2032582, rs4148738 with anemia in patients receiving dabigatran after total knee arthroplasty.
Kasimova A; Labutin D; Gvozdetsky A; Bozhkova S
Chin J Traumatol; 2024 Jan; 27(1):27-33. PubMed ID: 37423837
[TBL] [Abstract][Full Text] [Related]
19. Laboratory Monitoring or Measurement of Direct Oral Anticoagulants (DOACs): Advantages, Limitations and Future Challenges.
Favaloro EJ; Pasalic L; Curnow J; Lippi G
Curr Drug Metab; 2017; 18(7):598-608. PubMed ID: 28413976
[TBL] [Abstract][Full Text] [Related]
20. Direct Oral Anticoagulants in Cardioversion: A Review of Current Evidence.
Gibson CM; Basto AN; Howard ML
Ann Pharmacother; 2018 Mar; 52(3):277-284. PubMed ID: 29025267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
